Beyond the Angiogram: How FFR Helps Assess Coronary Blockages

3 July 2026 | Dr. Bhavesh Roy

Introduction: Looking Beyond the Appearance of a Blockage

Coronary angiography is an important investigation used to examine the arteries supplying blood to the heart. During the procedure, contrast material and X-ray imaging reveal the outline of the coronary arteries and help clinicians identify areas where the channel has narrowed.

However, the percentage of narrowing seen on an angiogram does not always tell the whole story. Two lesions that appear similar in size may have different effects on blood flow, depending on their length, location, shape, the amount of heart muscle they supply and other physiological factors.

For selected patients, a cardiologist may need to determine whether a narrowing actually restricts blood supply enough to explain symptoms or justify an intervention. This is particularly relevant when an angiogram shows an intermediate narrowing whose clinical significance is uncertain.

Fractional flow reserve, commonly known as FFR, is one technique used to answer this question. It measures pressure across a coronary narrowing under conditions designed to assess its effect on blood flow. The result adds functional information to the anatomical picture provided by angiography.

FFR may help guide decisions about whether to proceed with percutaneous coronary intervention (PCI), which can include balloon angioplasty and stent placement, or to manage a lesion with appropriate medical treatment. It is not necessary for every coronary angiogram, and it does not independently determine the best treatment for every patient.

This article explains how FFR works, how its values are interpreted, when clinicians may use it and why the result must be considered alongside the patient’s symptoms, other investigations and overall cardiovascular risk.

Table of Contents

1. What Is Fractional Flow Reserve (FFR)?
2. How an FFR Test Is Performed
3. Coronary Angiogram vs. FFR
4. What Do FFR Scores Mean?
5. Why FFR Can Help With Coronary Intervention Planning
6. Potential Benefits and Limitations of FFR
7. Who May Need an FFR Assessment?
8. Frequently Asked Questions
9. Key Takeaways
10. Conclusion

What Is Fractional Flow Reserve (FFR)?

Fractional flow reserve is an invasive physiological measurement used to assess the significance of a narrowing in a coronary artery. It is usually performed during coronary angiography when an additional assessment may help determine whether an intermediate lesion is limiting blood flow enough to justify revascularisation.

The coronary arteries supply oxygen-rich blood to the heart muscle. Atherosclerosis occurs when plaque develops within the artery walls, sometimes reducing the internal channel through which blood travels. Some narrowings significantly restrict blood supply during increased demand, while others may have a less pronounced physiological effect.

FFR helps evaluate this difference. During the measurement, a pressure-sensing wire records pressure beyond the narrowing. That pressure is compared with the pressure in the aorta during maximal coronary hyperaemia—a state in which the small coronary blood vessels have dilated and blood flow is increased.

In simplified terms, FFR is expressed as the ratio of pressure beyond the lesion to aortic pressure during maximal hyperaemia. It is intended to estimate the fraction of maximum blood flow available through the affected artery compared with the flow expected if the narrowing were not limiting it.

A value closer to 1.00 suggests that the lesion is having less physiological effect under the conditions measured. A lower value suggests a more significant pressure drop across the narrowing. The commonly used clinical threshold for considering a lesion physiologically significant is 0.80 or lower.

Why measure function as well as anatomy?

An angiogram shows the appearance of the coronary lumen, but visual estimation does not perfectly predict whether every narrowing limits blood flow. A lesion’s effect can depend on more than its apparent diameter reduction. A long, moderately narrowed segment may have a meaningful physiological effect, while some lesions that look moderately narrow may not significantly limit blood supply.

FFR can provide additional information when the angiogram alone leaves uncertainty. This may help the cardiologist decide whether a lesion is likely to benefit from an intervention or whether another management strategy should be considered.

FFR is not a direct image of plaque, and it does not show the complete structure of the artery wall. It also does not assess every aspect of coronary disease. A lesion can contain plaque that contributes to future cardiovascular risk even when its measured FFR is not in the range usually associated with flow limitation.

For this reason, FFR complements rather than replaces other clinical information, including symptoms, angiography, non-invasive test results and assessment of cardiovascular risk.

How an FFR Test Is Performed

FFR is generally measured in a cardiac catheterisation laboratory during invasive coronary angiography. It is performed when the treating cardiologist believes that assessing the physiological significance of a narrowing may influence a treatment decision.

1. Coronary catheterisation

The procedure usually begins with access through an artery in the wrist or groin. A catheter is guided through the blood vessels to the coronary arteries under X-ray guidance. Contrast material is injected to visualise the coronary anatomy and identify the narrowing being assessed.

If additional physiological information is needed, the cardiologist may proceed with FFR measurement during the same procedure.

2. Passing the pressure-sensing wire

A specialised guidewire with a pressure sensor near its tip is carefully passed through the catheter and positioned beyond the coronary narrowing. The pressure beyond the lesion is compared with a reference pressure, generally obtained in the aorta or through the guiding catheter.

The operator checks that the measurements are technically reliable and that the wire is positioned appropriately. The wire passes through a coronary artery, so the measurement requires care and is performed by a trained clinical team.

3. Increasing coronary blood flow

Conventional FFR measurement generally requires the coronary circulation to reach maximal hyperaemia. A medication such as adenosine may be given intravenously or directly into a coronary artery to dilate the small blood vessels and increase blood flow.

Maximal hyperaemia helps the pressure difference across the narrowing reflect its physiological significance more reliably. The medication and its route depend on the clinical setting, the patient’s medical history and the laboratory’s protocol.

Adenosine can cause temporary sensations such as warmth, flushing, chest discomfort or shortness of breath. These effects are often brief, but patients should tell the team about any symptoms they experience. If adenosine is unsuitable, the cardiologist may consider another assessment method when appropriate.

4. Calculating the FFR value

During the measurement, the system records pressure beyond the lesion and compares it with the aortic reference pressure under the required conditions. The resulting ratio is expressed as an FFR value, usually between 0 and 1.

The cardiologist interprets the value alongside the angiogram, the symptoms and the broader clinical situation. If the measurement suggests that the lesion significantly restricts blood flow, PCI may be considered when otherwise appropriate. If the measurement indicates no significant flow limitation, the team may decide to defer stenting and continue appropriate medical management.

The test does not automatically lead to angioplasty. The decision depends on the full assessment, including the presence of symptoms, coronary anatomy, other physiological results and the likely benefit and risks of intervention.

Is FFR the only physiological option?

No. Instantaneous wave-free ratio (iFR) and other resting pressure indices can assess the physiological significance of selected coronary lesions without the same requirement for medication-induced maximal hyperaemia. These methods use different measurement conditions and have their own validated thresholds.

FFR and iFR are related but their numerical values are not interchangeable. A clinician chooses the appropriate method according to the lesion, patient factors, local practice and the clinical question being addressed.

Coronary Angiogram vs. FFR

Coronary angiography and FFR provide different types of information. Angiography shows the anatomy of the coronary arteries, while FFR assesses the physiological effect of a particular narrowing during increased coronary blood flow.

The two methods are complementary. FFR does not replace angiography because the cardiologist still needs to understand the location and anatomy of the lesion. Angiography, in turn, may not provide sufficient information to determine the physiological significance of every intermediate narrowing.

The 2021 ACC/AHA/SCAI coronary revascularisation guideline recommends using FFR or iFR to guide the decision about PCI in appropriate patients with anginal symptoms, no previously documented ischaemia and angiographically intermediate stenoses. For stable patients with an intermediate lesion and an FFR above 0.80 or iFR above 0.89, PCI should generally not be performed solely for that lesion.

These recommendations apply in the context of the clinical indication and the specific lesion being evaluated. They do not mean that FFR replaces clinical judgement or that every patient with chest pain requires an invasive test.

Decoding the Data: What Do FFR Scores Mean?

An FFR result helps the clinician assess how much a particular narrowing affects the pressure available beyond the lesion during maximal coronary hyperaemia. The result is useful, but it must not be confused with a direct measurement of the exact percentage of blood flow lost.

Important: The FFR threshold is used to guide a clinical decision; it is not an automatic instruction to insert or withhold a stent. The significance of a lesion also depends on the amount of heart muscle it supplies, symptoms, other test findings, technical measurement quality and other relevant factors.

What does an FFR of 0.80 mean?

An FFR of 0.80 indicates that the measured ratio of pressure beyond the narrowing to the reference aortic pressure is 0.80 under the test conditions. It should not be interpreted as proof that blood flow has fallen by exactly 20% in every situation.

In selected patients with stable coronary disease, an FFR of 0.80 or below may support revascularisation when the lesion is responsible for symptoms or otherwise appropriate to treat. The expected advantages and risks of PCI must still be considered.

What if the FFR is above 0.80?

An FFR above 0.80 generally supports deferring PCI for an intermediate lesion when the rest of the clinical picture is consistent. This does not mean the artery is completely free of plaque or that the patient has no cardiovascular risk. The person may still need medication, risk-factor management and follow-up according to their diagnosis.

If symptoms persist despite a non-significant FFR result, clinicians may consider other causes, additional physiological assessment or alternative testing. For example, some people have coronary microvascular dysfunction or vasospasm, which may not be fully explained by the FFR result from a particular epicardial lesion.

How should a borderline result be interpreted?

Values close to the threshold need careful interpretation. The cardiologist considers measurement quality, lesion anatomy, symptoms, the amount of myocardium supplied, and other available information. Sometimes additional testing or a different physiological assessment may be appropriate.

FFR is most useful when it helps answer a specific clinical question. It should not be used in isolation to make a broad statement about the health of the entire coronary circulation.

Why FFR Can Help With Coronary Intervention Planning

FFR can be especially useful when an angiogram shows several narrowings or when a lesion’s functional significance is unclear. It can help the heart team identify which lesions may be contributing to reduced blood supply and which may not require a stent at that time.

1. Assessment of intermediate lesions

Intermediate lesions are narrowings that do not appear clearly mild or clearly severe on angiography. Their physiological significance can be difficult to judge from appearance alone. FFR or iFR may help determine whether a lesion warrants revascularisation.

Professional guidelines recommend physiological assessment for appropriate patients with symptoms and intermediate coronary stenoses when the result is likely to guide a PCI decision.

2. Planning care in multivessel coronary disease

Some patients have more than one narrowing across different coronary arteries. The angiogram may show several lesions, but their impact on blood supply can differ. Physiological assessment can help clarify the significance of selected lesions.

However, FFR does not independently determine whether a patient should receive PCI or coronary artery bypass grafting (CABG). The choice between catheter-based treatment, bypass surgery and medical management requires consideration of the complexity and distribution of disease, heart function, other medical conditions, surgical risk, expected outcomes and patient preferences.

For some patients with complex multivessel disease, a multidisciplinary heart team assessment is appropriate. FFR can contribute useful information, but it does not replace that broader decision-making process.

3. Supporting a decision to defer stenting

If FFR suggests that an intermediate lesion is not significantly restricting blood flow, the cardiologist may decide that placing a stent is unlikely to provide enough benefit at that time. This can help avoid a procedure that may not be clinically necessary for that particular lesion.

Deferring a stent does not mean doing nothing. The treatment plan may include medication, control of cholesterol and blood pressure, diabetes management, smoking cessation when relevant and follow-up. Patients should continue the recommended care plan even when a lesion does not require intervention.

4. Helping identify lesions that may benefit from revascularisation

When a lesion is physiologically significant and the clinical assessment supports intervention, FFR can provide information that helps guide the revascularisation decision. Evidence from clinical trials, including the FAME studies, supports the role of FFR-guided decision-making in selected patients with coronary disease.

The benefit depends on the circumstances. Trial results should not be interpreted as a guarantee of fewer heart attacks or better outcomes for every person undergoing FFR. The overall treatment plan and long-term medical management remain important.

5. Particular care in acute coronary syndromes

FFR is not a test that should delay urgent treatment when a person has an acute heart attack requiring immediate reperfusion. In an emergency, the clinical presentation and angiographic findings guide urgent care.

Physiological assessment may have a role in selected patients with acute coronary syndromes, particularly when evaluating certain non-culprit lesions, but its use depends on the clinical setting and the limitations of physiological measurements during an acute event. The treating team determines whether the measurement is appropriate.

Potential Benefits and Limitations of FFR

FFR provides a way to add physiological information to the anatomical findings from coronary angiography. When used for the appropriate clinical question, it can support more informed treatment decisions.

Potential benefits

• More information about lesion significance: FFR can help assess whether an intermediate narrowing limits blood supply under the conditions measured.
• Support for treatment planning: The result can help the cardiologist decide whether PCI is likely to offer a meaningful benefit for a particular lesion.
• Avoiding some unnecessary interventions: In appropriate stable patients, physiological findings may support deferring stenting for lesions that are not significantly flow-limiting.
• Improved assessment in selected complex cases: FFR can help clarify which lesions are functionally significant when several narrowings are present.

Limitations to understand

FFR is an invasive measurement performed through coronary catheterisation. It does not provide a complete picture of plaque composition or overall cardiovascular risk. It also depends on appropriate technique and physiological conditions, and certain clinical settings can affect how the result should be interpreted.

FFR-guided decisions do not remove all risks associated with angiography or PCI. Catheter-based procedures can involve bleeding, vascular complications, contrast-related problems, abnormal heart rhythms and, rarely, injury to a coronary artery.

Medication used to induce hyperaemia, such as adenosine, may cause temporary shortness of breath, flushing, chest discomfort or other transient effects. Certain medical conditions can affect which medication or measurement approach is suitable, so patients should disclose their health history and current medicines to the care team.

The practical value of FFR lies in using it when the additional physiological information can help answer a relevant clinical question. It is not a requirement for every coronary lesion or every angiography procedure.

Who May Need an FFR Assessment?

FFR is generally considered when a cardiologist identifies a coronary narrowing whose physiological significance is uncertain and when the result could affect treatment. The decision depends on the clinical situation, symptoms, anatomy and other investigation findings.

Situations where FFR may be considered

• Intermediate coronary narrowing: An angiogram shows a lesion whose impact on blood flow cannot be confidently determined from appearance alone.
• Stable exertional symptoms: A patient has suspected angina or an angina-equivalent symptom, and invasive coronary angiography reveals an intermediate lesion whose significance remains uncertain.
• Multivessel coronary disease: Several lesions are present, and physiological assessment may help clarify the contribution of selected narrowings.
• Unclear treatment decisions: The angiographic findings and the person’s symptoms or other test results do not provide a sufficiently clear answer about whether a specific lesion should be treated.

When might FFR not be needed?

FFR is not necessary for every patient undergoing coronary angiography. Some lesions are clearly mild and unlikely to need intervention, while others may be clearly severe in the appropriate clinical setting. The need for physiological assessment depends on whether additional information is likely to change management.

In an acute heart attack requiring urgent treatment of the culprit artery, reperfusion should not be delayed simply to perform an FFR measurement. The role of pressure-based assessment in other lesions during acute coronary syndromes is determined by the clinical context.

Patients with suspected coronary disease who have not yet undergone invasive angiography may also be assessed with non-invasive tests, depending on their clinical risk. FFR performed with an intracoronary pressure wire is distinct from CT-derived FFR, which estimates physiological significance from coronary CT angiography using specialised computer analysis.

What should you ask your cardiologist?

If an FFR test has been suggested, useful questions include why the narrowing is considered uncertain, how the result might change the treatment plan, whether an alternative physiological assessment is appropriate and what risks are relevant to you.

Ask how the result will be interpreted alongside your symptoms and other test findings. Understanding the purpose of the test can help you participate in decisions about medical treatment, PCI or other options.

Frequently Asked Questions (FAQs)

1. Is the FFR test painful?

The pressure-wire measurement is usually performed through the same catheter access used for coronary angiography. The access-site procedure may cause discomfort, and the medication used to induce hyperaemia can temporarily produce flushing, chest discomfort or shortness of breath. Tell the clinical team if you experience symptoms during the test.

2. Does a high FFR score mean my artery is completely clear?

No. An FFR above 0.80 generally indicates that the assessed lesion is not physiologically significant according to the commonly used threshold. It does not mean that the artery is free of plaque or that your overall cardiovascular risk is absent. Medication and risk-factor management may still be important.

3. How long does an FFR assessment take?

The additional time varies depending on the number of lesions, the technical requirements, the patient’s condition and whether further assessment or treatment is needed. It is best to ask the treating team about the expected duration for your planned procedure rather than rely on a fixed estimate.

4. Are there risks associated with an FFR test?

FFR is performed during invasive coronary catheterisation and shares its procedural risks, including bleeding, vascular injury and other uncommon complications. The pressure wire also carries a small risk of coronary injury. Medication used to induce hyperaemia may cause brief side effects. The clinical team considers the benefits and risks for each patient.

5. Does an FFR value of 0.80 mean blood flow has fallen by 20%?

No. FFR is a ratio of pressure beyond a coronary lesion to the reference aortic pressure during maximal hyperaemia. It is used to estimate the physiological significance of a narrowing, but it does not mean blood flow has fallen by exactly the same percentage in every patient or lesion.

6. If my FFR is above 0.80, can I stop heart medication?

No. An FFR result does not replace the broader treatment plan for coronary artery disease. Your clinician may recommend medication to manage cholesterol, blood pressure, diabetes or other risks even if the particular lesion does not require a stent. Do not stop prescribed medication without medical advice.

7. Is FFR performed during every angiogram?

No. It is used selectively when assessing the functional significance of a narrowing is likely to help guide a clinical decision. Whether it is required depends on the anatomy, symptoms, other findings and the purpose of the investigation.

8. Is FFR the same as iFR?

No. Both are pressure-based methods used to assess the physiological significance of coronary lesions, but they use different measurement conditions. Conventional FFR generally uses medication to induce maximal hyperaemia, whereas iFR is measured during a specific resting phase of the cardiac cycle and usually does not require that medication. Their thresholds are different.

Key Takeaways

• An angiogram and FFR answer different questions: Angiography shows coronary anatomy, while FFR assesses the physiological significance of a selected narrowing.
• FFR is useful for selected intermediate lesions: The result can help guide decisions about whether PCI is appropriate.
• An FFR threshold is not an automatic treatment order: A value of 0.80 or below is generally considered physiologically significant, but treatment decisions depend on the broader clinical assessment.
• A value above 0.80 does not mean the artery is plaque-free: Medical management and cardiovascular risk reduction may still be needed.
• FFR has limitations and risks: It is an invasive procedure, requires appropriate interpretation and is not necessary for every angiogram.
• Emergency care takes priority: FFR should not delay urgent treatment when a person has an acute heart attack requiring immediate intervention.

Conclusion

Coronary angiography provides important anatomical information, but the appearance of a narrowing does not always establish its physiological significance. Fractional flow reserve adds another layer of information by measuring pressure beyond a lesion and comparing it with aortic pressure during maximal coronary hyperaemia.

For selected patients with intermediate coronary stenoses, FFR can help guide a decision about whether a lesion is likely to benefit from PCI or whether intervention can be deferred while appropriate medical treatment continues. Its value is greatest when it answers a specific clinical question that cannot be resolved adequately by angiography alone.

An FFR value should not be interpreted as an exact percentage of lost blood flow or as an automatic instruction to insert or avoid a stent. The cardiologist must consider the person’s symptoms, coronary anatomy, other investigations, clinical risks and treatment goals.

When FFR is appropriate, it can support more informed coronary treatment planning. When it is not necessary or the clinical situation requires another approach, other diagnostic and treatment options remain available. Patients should discuss the reason for the proposed assessment, the possible outcomes and the alternatives with their treating cardiologist.